Extent and causes of the collapse in the registration of innovative medications in Lebanon: A mixed-methods analysis
Health systems are complex adaptive systems, where policies affecting innovative drug approvals may not only delay access, but also trigger unintended consequences. In Lebanon, the registration of innovative medications should remain independent from reimbursement decisions and grounded in evidence-informed health policies.
Authors
- Soumana C. Nasser (ORCID: https://orcid.org/0000-0003-4202-7116)
- Wadih Mina
- Louis P. Garrison (ORCID: https://orcid.org/0000-0002-9468-4989)
- Maria Rita Lteif (ORCID: https://orcid.org/0009-0009-4424-8968)
- hanadi Nahas
- Fadi El-Jardali
- Rita Karam
Institutions
- Lebanese University (LB)
- University of Washington (US)
- Orient-Institut Beirut (LB)
- Lebanese American University (LB)
- American University of Beirut (LB)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-12-26
- DOI
- https://doi.org/10.1371/journal.pone.0330585
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00